KNSA - Kiniksa Pharmaceuticals International, plc
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$70.80
DETAILS
HIGH:
$75.00
LOW:
$62.00
MEDIAN:
$72.00
CONSENSUS:
$70.80
DOWNSIDE:
10.88%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||
| Revenue | 677.6 | 423.2 | 270.3 | 220.2 | 38.5 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 307.4 | 60.9 | 56.5 | 22.9 | 9.1 | 3.8 | 3.3 | 0.3 | 0.0 | 0.0 |
| Gross Profit | 370.1 | 362.3 | 213.7 | 197.3 | 29.4 | (3.8) | (3.3) | (0.3) | (0.0) | (0.0) |
| Operating Expenses | ||||||||||
| R&D Expenses | 96.9 | 111.6 | 76.1 | 65.5 | 99.3 | 109.6 | 132.9 | 86.6 | 56.4 | 17.4 |
| SG&A Expenses | 196.3 | 168.0 | 129.4 | 98.0 | 85.9 | 43.9 | 33.8 | 21.6 | 9.0 | 6.6 |
| Other Expenses | 0 | 128.3 | 33.4 | 24.1 | 0.8 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 292.9 | 407.9 | 238.9 | 187.5 | 186.1 | 153.6 | 166.7 | 108.2 | 65.4 | 24.0 |
| Operating Income | ||||||||||
| Operating Income | 77.2 | (45.6) | (25.2) | 9.8 | (156.6) | (157.4) | (170.0) | (108.2) | (65.4) | (24.0) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 11.6 | 9.5 | 8.5 | 1.3 | 0.1 | 1.1 | 6.0 | 4.7 | 0.5 | 0.1 |
| Profitability | ||||||||||
| EBITDA | 90.4 | (34.5) | (14.3) | 13.4 | (154.2) | (152.4) | (160.6) | (107.9) | (65.4) | (24.0) |
| EBIT | 88.9 | (36.2) | (16.7) | 11.0 | (156.5) | (156.2) | (163.9) | (108.2) | (65.4) | (24.0) |
| Income Before Tax | 88.9 | (36.2) | (16.7) | 11.0 | (156.5) | (156.2) | (163.9) | (103.4) | (64.9) | (23.9) |
| Income Tax Expense | 29.9 | 7.0 | (30.7) | (172.3) | 1.4 | 5.2 | (2.0) | (0.2) | 0.0 | 0.0 |
| Net Income | 59.0 | (43.2) | 14.1 | 183.4 | (157.9) | (161.4) | (161.9) | (103.2) | (64.9) | (24.0) |
| Per Share Data | ||||||||||
| EPS (Basic) | 0.80 | -0.60 | 0.20 | 2.64 | -2.30 | -2.61 | -2.99 | -3.49 | -2.00 | -0.74 |
| EPS (Diluted) | 0.75 | -0.60 | 0.20 | 2.60 | -2.30 | -2.61 | -2.99 | -3.49 | -2.00 | -0.74 |
| Shares Outstanding | 74.2 | 71.4 | 70.1 | 69.4 | 68.6 | 61.8 | 54.0 | 29.5 | 32.5 | 32.5 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 165.6 | 183.6 | 108.0 | 122.7 | 122.5 | 114.0 | 46.9 | 307.3 | 45.6 | 56.0 |
| Short-Term Investments | 248.5 | 60.0 | 98.4 | 67.9 | 59.7 | 209.4 | 186.5 | 0 | 0 | 0 |
| Net Receivables | 15.6 | 41.7 | 21.3 | 20.3 | 4.0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 54.9 | 26.4 | 31.1 | 21.6 | 3.7 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 42.6 | 20.1 | 17.5 | 10.5 | 0 | 0.2 | 0 | 6.4 | 0.1 | 0.1 |
| Total Current Assets | 527.2 | 331.8 | 276.3 | 243.1 | 196.4 | 333.2 | 241.6 | 313.8 | 47.1 | 56.3 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 11.8 | 11.0 | 12.7 | 7.0 | 8.4 | 10.6 | 8.3 | 6.4 | 0.1 | 0.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 15.2 | 16.2 | 17.2 | 18.2 | 19.2 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | 0 | 0 |
| Other Non-Current Assets | 11.3 | 10.3 | 0.8 | 5.8 | 8.7 | 5.6 | 0.2 | 0.6 | 0.0 | 0.0 |
| Total Non-Current Assets | 236.5 | 248.8 | 250.0 | 216.6 | 36.4 | 16.2 | 12.9 | 8.2 | 0.4 | 0.1 |
| Total Assets | 763.6 | 580.6 | 526.3 | 459.7 | 232.8 | 349.5 | 254.5 | 322.0 | 47.5 | 56.5 |
| Current Liabilities | ||||||||||
| Account Payables | 2.0 | 2.0 | 8.2 | 7.9 | 1.9 | 0.5 | 5.7 | 10.9 | 1.2 | 0.2 |
| Short-Term Debt | 3.0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 31.8 | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 102.4 | 33.1 | 36.9 | 17.0 | 1.5 | 7.7 | 7.1 | 26.0 | 14.6 | 1.1 |
| Total Current Liabilities | 139.2 | 100.6 | 63.7 | 47.1 | 44.8 | 31.8 | 27.8 | 42.6 | 17.4 | 2.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.2 | 0 | 0 |
| Other Non-Current Liabilities | 18.5 | 1.8 | 1.9 | 1.8 | 0.3 | 0.8 | 0.3 | 0.1 | 119.8 | 79.9 |
| Total Non-Current Liabilities | 56.8 | 41.5 | 23.8 | 16.5 | 2.9 | 5.7 | 1.3 | 0.1 | 119.8 | 79.9 |
| Total Liabilities | 196.0 | 142.1 | 87.5 | 63.5 | 47.8 | 37.5 | 29.1 | 42.7 | 137.2 | 82.2 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (462.1) | (521.1) | (477.9) | (492.0) | (675.4) | (517.5) | (356.1) | (194.2) | (91.0) | (26.1) |
| Accumulated Other Comprehensive Income | (0.0) | (0.2) | 0.0 | 0.0 | (0.1) | (0.0) | 0.0 | (0.0) | (0.1) | (0.0) |
| Total Stockholders' Equity | 567.6 | 438.4 | 438.8 | 396.1 | 185.0 | 311.9 | 225.4 | (194.2) | (89.7) | (25.7) |
| Total Liabilities & Equity | 763.6 | 580.6 | 526.3 | 459.7 | 232.8 | 349.5 | 254.5 | (151.5) | 47.5 | 56.5 |
| Debt Metrics | ||||||||||
| Total Debt | 9.5 | 9.9 | 12.3 | 5.9 | 6.0 | 7.0 | 2.7 | 0 | 0 | 0 |
| Net Debt | (156.1) | (173.7) | (95.7) | (116.8) | (116.4) | (107.1) | (44.3) | (307.3) | (45.6) | (56.0) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (43.2) | (43.2) | 14.1 | 183.4 | (157.9) | (161.4) | (161.9) | (103.2) | (64.9) | (24.0) |
| Depreciation & Amortization | 1.7 | 1.7 | 2.3 | 2.4 | 2.4 | 2.4 | 2.1 | 0.3 | 0.0 | 0.0 |
| Stock-Based Compensation | 30.7 | 30.7 | 27.1 | 25.1 | 25.2 | 20.9 | 15.1 | 5.7 | 0.9 | 0.4 |
| Change in Working Capital | 51.6 | 24.8 | 1.4 | (22.6) | 0.7 | (4.3) | (17.0) | 18.3 | 13.9 | 1.8 |
| Other Non-Cash Items | (23.3) | 3.6 | 2.2 | 3.0 | 3.4 | 1.5 | 6.5 | (1.1) | (0.1) | 0.3 |
| Operating Cash Flow | 25.7 | 25.7 | 13.3 | 5.8 | (126.3) | (136.5) | (158.4) | (81.0) | (50.2) | (21.9) |
| Investing Activities | ||||||||||
| Capital Expenditure | (0.3) | (0.3) | (0.1) | (0.1) | (20.4) | (0.3) | (3.2) | (5.3) | (0.1) | (0.0) |
| Acquisitions | 0 | 0.0 | 0 | 0 | 0 | 23.2 | (52.4) | 0 | 0 | 0 |
| Purchases of Investments | (202.0) | (202.0) | (204.9) | (135.9) | (157.2) | (430.2) | (488.8) | (402.0) | 0 | 0 |
| Sales/Maturities of Investments | 239.9 | 239.9 | 175.5 | 127.8 | 306.3 | 407.1 | 541.2 | 168.1 | 0 | 0 |
| Other Investing Activities | 0.0 | 0 | 0 | 0.1 | (20) | (23.2) | 52.4 | (233.9) | 0 | 0 |
| Investing Cash Flow | 37.7 | 37.7 | (29.6) | (8.1) | 128.6 | (23.4) | 49.2 | (239.2) | (0.1) | (0.0) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | (7.7) | (5.0) | (2.2) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 20.0 | 17.2 | 3.7 | (0.9) | 0 | (1.1) | 1.0 | (3.3) | 0 | 0.0 |
| Financing Cash Flow | 12.3 | 12.3 | 1.5 | 2.5 | 5.9 | 227.1 | 84.1 | 346.7 | 39.9 | 42.5 |
| Cash Position | ||||||||||
| Net Change in Cash | 75.6 | 75.6 | (14.8) | 0.2 | 8.2 | 67.1 | (25.0) | 26.5 | (10.4) | 20.6 |
| Cash at Beginning | 108.0 | 108.0 | 122.7 | 122.5 | 114.2 | 47.1 | 72.2 | 45.7 | 56.1 | 35.4 |
| Cash at End | 183.6 | 183.6 | 108.0 | 122.7 | 122.5 | 114.2 | 47.1 | 72.2 | 45.7 | 56.1 |
| Free Cash Flow | 25.4 | 25.4 | 13.2 | 5.7 | (146.7) | (136.8) | (161.6) | (86.3) | (50.3) | (21.9) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 677.6 | 423.2 | 270.3 | 220.2 | 38.5 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 370.1 | 362.3 | 213.7 | 197.3 | 29.4 | (3.8) | (3.3) | (0.3) | (0.0) | (0.0) |
| Operating Income | 77.2 | (45.6) | (25.2) | 9.8 | (156.6) | (157.4) | (170.0) | (108.2) | (65.4) | (24.0) |
| Net Income | 59.0 | (43.2) | 14.1 | 183.4 | (157.9) | (161.4) | (161.9) | (103.2) | (64.9) | (24.0) |
| EPS (Diluted) | 0.75 | -0.60 | 0.20 | 2.60 | -2.30 | -2.61 | -2.99 | -3.49 | -2.00 | -0.74 |
| Balance Sheet | ||||||||||
| Cash & Equivalents | 165.6 | 183.6 | 108.0 | 122.7 | 122.5 | 114.0 | 46.9 | 307.3 | 45.6 | 56.0 |
| Total Assets | 763.6 | 580.6 | 526.3 | 459.7 | 232.8 | 349.5 | 254.5 | 322.0 | 47.5 | 56.5 |
| Total Debt | 9.5 | 9.9 | 12.3 | 5.9 | 6.0 | 7.0 | 2.7 | 0 | 0 | 0 |
| Stockholders' Equity | 567.6 | 438.4 | 438.8 | 396.1 | 185.0 | 311.9 | 225.4 | (194.2) | (89.7) | (25.7) |
| Cash Flow | ||||||||||
| Operating Cash Flow | 25.7 | 25.7 | 13.3 | 5.8 | (126.3) | (136.5) | (158.4) | (81.0) | (50.2) | (21.9) |
| Capital Expenditure | (0.3) | (0.3) | (0.1) | (0.1) | (20.4) | (0.3) | (3.2) | (5.3) | (0.1) | (0.0) |
| Free Cash Flow | 25.4 | 25.4 | 13.2 | 5.7 | (146.7) | (136.8) | (161.6) | (86.3) | (50.3) | (21.9) |